Neeraj Agarwal, MD, FASCO, observed remarkable outcomes in a larger group of Talapro-2 participants with specific gene mutations, combining two cancer drugs to effectively treat advanced prostate cancer.
MasterControl, a long-time Huntsman SportsFest sponsor, empowers our clinical trials and research teams to operate more efficiently and focus on advancing cancer care through its software and staff donations.
Read how scientists reduce infection risk after pancreatic surgery, discover the best cost-effective treatment for prostate cancer, learn which lung cancer patients have the most emergency department visits, and more.
The new treatment combines a modified cold virus injected directly into a tumor and an immunotherapy drug given intravenously. This breakthrough comes after many years of pre-clinical and clinical studies.